Loading...

Karla Kerlikowske, MD

TitleProfessor
InstitutionUniversity of California San Francisco
DepartmentMedicine
AddressVAMC Bldg 18
San Francisco CA 94121
Phone415-750-2093
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of California, San Francisco Residency School of Medicine
    University of California, San FranciscoM.D.1988School of Medicine
    Collapse Awards and Honors
    2014Society of General Internal Medicine Distinguished Professor in Cancer Research
    2016Journal of Women’s Health Award for Outstanding Achievement in Women’s Health Research
    2017Global Health and Pharma Epidemiology & Biostatistics Prof of the Year - West USA & Best for Cancer

    Collapse Research 
    Collapse Research Activities and Funding
    Radiomic phenotypes of breast parenchyma and association with breast cancer risk and detection
    NIH/NCI R01CA207084Apr 1, 2017 - Mar 31, 2022
    Role: Co-Principal Investigator
    Automated Density Measures for Estimating Breast Cancer Risk and Therapy Response
    NIH/NCI R01CA177150Sep 1, 2013 - Aug 31, 2018
    Role: Co-Principal Investigator
    Risk-based Breast Cancer Screening and Surveillance in Community Practice
    NIH/NCI P01CA154292Sep 27, 2011 - May 31, 2022
    Role: Co-Principal Investigator
    Risk factors for breast cancer molecular subtypes
    NIH/NCI R01CA140286Apr 1, 2010 - Jan 31, 2015
    Role: Co-Principal Investigator
    Comparative effectiveness of breast imaging strategies in community practice
    NIH/NCI UC2CA148577Sep 30, 2009 - Aug 31, 2012
    Role: Co-Principal Investigator
    Comparative effectiveness of breast imaging strategies in community practice
    NIH/NCI RC2CA148577Sep 30, 2009 - Aug 31, 2011
    Role: Co-Principal Investigator
    Biological Basis of Breast Density and Cancer Risk
    NIH/NCI P01CA107584Aug 10, 2006 - Feb 28, 2013
    Role: Co-Investigator
    San Francisco Mammography Registry-A Research Source
    NIH/NCI U01CA063740Jun 1, 1994 - Jul 31, 2012
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Websites
    Collapse In The News
    Collapse Featured Videos

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Karliner LS, Kaplan C, Livaudais-Toman J, Kerlikowske K. Mammography facilities serving vulnerable women have longer follow-up times. Health Serv Res. 2018 Nov 05. PMID: 30394526.
      View in: PubMed
    2. Kontos D, Winham SJ, Oustimov A, Pantalone L, Hsieh MK, Gastounioti A, Whaley DH, Hruska CB, Kerlikowske K, Brandt K, Conant EF, Vachon CM. Radiomic Phenotypes of Mammographic Parenchymal Complexity: Toward Augmenting Breast Density in Breast Cancer Risk Assessment. Radiology. 2018 Oct 30; 180179. PMID: 30375931.
      View in: PubMed
    3. Lee CI, Zhu W, Onega TL, Germino J, O'Meara ES, Lehman CD, Henderson LM, Haas JS, Kerlikowske K, Sprague BL, Rauscher GH, Tosteson ANA, Alford-Teaster J, Wernli KJ, Miglioretti DL. The Effect of Digital Breast Tomosynthesis Adoption on Facility-Level Breast Cancer Screening Volume. AJR Am J Roentgenol. 2018 Sep 20; W1-W7. PMID: 30235000.
      View in: PubMed
    4. Lee JM, Abraham L, Lam DL, Buist DSM, Kerlikowske K, Miglioretti DL, Houssami N, Lehman CD, Henderson LM, Hubbard RA. Cumulative Risk Distribution for Interval Invasive Second Breast Cancers After Negative Surveillance Mammography. J Clin Oncol. 2018 May 02; JCO2017768267. PMID: 29718790.
      View in: PubMed
    5. Kerlikowske K, Scott CG, Mahmoudzadeh AP, Ma L, Winham S, Jensen MR, Wu FF, Malkov S, Pankratz VS, Cummings SR, Shepherd JA, Brandt KR, Miglioretti DL, Vachon CM. Automated and Clinical Breast Imaging Reporting and Data System Density Measures Predict Risk of Screen-Detected and Interval Cancers. Ann Intern Med. 2018 May 01. PMID: 29710124.
      View in: PubMed
    6. Braithwaite D, Miglioretti DL, Zhu W, Demb J, Trentham-Dietz A, Sprague B, Tice JA, Onega T, Henderson LM, Buist DSM, Ziv E, Walter LC, Kerlikowske K. Family History and Breast Cancer Risk Among Older Women in the Breast Cancer Surveillance Consortium Cohort. JAMA Intern Med. 2018 Apr 01; 178(4):494-501. PMID: 29435563.
      View in: PubMed
    7. Buist DSM, Abraham L, Lee CI, Lee JM, Lehman C, O'Meara ES, Stout NK, Henderson LM, Hill D, Wernli KJ, Haas JS, Tosteson ANA, Kerlikowske K, Onega T. Breast Biopsy Intensity and Findings Following Breast Cancer Screening in Women With and Without a Personal History of Breast Cancer. JAMA Intern Med. 2018 Apr 01; 178(4):458-468. PMID: 29435556.
      View in: PubMed
    8. Rice MS, Tamimi RM, Bertrand KA, Scott CG, Jensen MR, Norman AD, Visscher DW, Chen YY, Brandt KR, Couch FJ, Shepherd JA, Fan B, Wu FF, Ma L, Collins LC, Cummings SR, Kerlikowske K, Vachon CM. Does mammographic density mediate risk factor associations with breast cancer? An analysis by tumor characteristics. Breast Cancer Res Treat. 2018 Mar 03. PMID: 29502324.
      View in: PubMed
    9. Henderson LM, Hubbard RA, Zhu W, Weiss J, Wernli KJ, Goodrich ME, Kerlikowske K, DeMartini W, Ozanne EM, Onega T. Preoperative Breast Magnetic Resonance Imaging Use by Breast Density and Family History of Breast Cancer. J Womens Health (Larchmt). 2018 Jan 15. PMID: 29334616.
      View in: PubMed
    10. Hill DA, Haas JS, Wellman R, Hubbard RA, Lee CI, Alford-Teaster J, Wernli KJ, Henderson LM, Stout NK, Tosteson ANA, Kerlikowske K, Onega T. Utilization of breast cancer screening with magnetic resonance imaging in community practice. J Gen Intern Med. 2018 Mar; 33(3):275-283. PMID: 29214373.
      View in: PubMed
    11. Onega T, Weiss JE, Goodrich ME, Zhu W, DeMartini WB, Kerlikowske K, Ozanne E, Tosteson ANA, Henderson LM, Buist DSM, Wernli KJ, Herschorn SD, Hotaling E, O'Donoghue C, Hubbard R. Relationship between preoperative breast MRI and surgical treatment of non-metastatic breast cancer. J Surg Oncol. 2017 Dec; 116(8):1008-1015. PMID: 29127715.
      View in: PubMed
    12. Ray KM, Kerlikowske K, Lobach IV, Hofmann MB, Greenwood HI, Arasu VA, Hylton NM, Joe BN. Effect of Background Parenchymal Enhancement on Breast MR Imaging Interpretive Performance in Community-based Practices. Radiology. 2018 03; 286(3):822-829. PMID: 29072981.
      View in: PubMed
    13. Shiyanbola OO, Arao RF, Miglioretti DL, Sprague BL, Hampton JM, Stout NK, Kerlikowske K, Braithwaite D, Buist DSM, Egan KM, Newcomb PA, Trentham-Dietz A. Emerging Trends in Family History of Breast Cancer and Associated Risk. Cancer Epidemiol Biomarkers Prev. 2017 Dec; 26(12):1753-1760. PMID: 28986348.
      View in: PubMed
    14. Engmann NJ, Golmakani MK, Miglioretti DL, Sprague BL, Kerlikowske K. Population-Attributable Risk Proportion of Clinical Risk Factors for Breast Cancer. JAMA Oncol. 2017 Sep 01; 3(9):1228-1236. PMID: 28152151.
      View in: PubMed
    15. Yu J, Nagler RH, Fowler EF, Kerlikowske K, Gollust SE. Women's Awareness and Perceived Importance of the Harms and Benefits of Mammography Screening: Results From a 2016 National Survey. JAMA Intern Med. 2017 Sep 01; 177(9):1381-1382. PMID: 28654987.
      View in: PubMed
    16. Kerlikowske K, Ma L, Scott CG, Mahmoudzadeh AP, Jensen MR, Sprague BL, Henderson LM, Pankratz VS, Cummings SR, Miglioretti DL, Vachon CM, Shepherd JA. Combining quantitative and qualitative breast density measures to assess breast cancer risk. Breast Cancer Res. 2017 Aug 22; 19(1):97. PMID: 28830497.
      View in: PubMed
    17. Shieh Y, Hu D, Ma L, Huntsman S, Gard CC, Leung JWT, Tice JA, Ziv E, Kerlikowske K, Cummings SR. Joint relative risks for estrogen receptor-positive breast cancer from a clinical model, polygenic risk score, and sex hormones. Breast Cancer Res Treat. 2017 Nov; 166(2):603-612. PMID: 28791495.
      View in: PubMed
    18. Yaghjyan L, Tamimi RM, Bertrand KA, Scott CG, Jensen MR, Pankratz VS, Brandt K, Visscher D, Norman A, Couch F, Shepherd J, Fan B, Chen YY, Ma L, Beck AH, Cummings SR, Kerlikowske K, Vachon CM. Interaction of mammographic breast density with menopausal status and postmenopausal hormone use in relation to the risk of aggressive breast cancer subtypes. Breast Cancer Res Treat. 2017 Sep; 165(2):421-431. PMID: 28624977.
      View in: PubMed
    19. Nguyen KH, Pasick RJ, Stewart SL, Kerlikowske K, Karliner LS. Disparities in abnormal mammogram follow-up time for Asian women compared with non-Hispanic white women and between Asian ethnic groups. Cancer. 2017 Sep 15; 123(18):3468-3475. PMID: 28603859.
      View in: PubMed
    20. Lee JM, Ichikawa L, Valencia E, Miglioretti DL, Wernli K, Buist DSM, Kerlikowske K, Henderson LM, Sprague BL, Onega T, Rauscher GH, Lehman CD. Performance Benchmarks for Screening Breast MR Imaging in Community Practice. Radiology. 2017 10; 285(1):44-52. PMID: 28582633.
      View in: PubMed
    21. Tice JA, Kerlikowske K. Supplemental Breast Cancer Screening: A Density Conundrum. J Gen Intern Med. 2017 Jun; 32(6):593-594. PMID: 28243876.
      View in: PubMed
    22. Miglioretti DL, Ichikawa L, Smith RA, Buist DSM, Carney PA, Geller B, Monsees B, Onega T, Rosenberg R, Sickles EA, Yankaskas BC, Kerlikowske K. Correlation Between Screening Mammography Interpretive Performance on a Test Set and Performance in Clinical Practice. Acad Radiol. 2017 Oct; 24(10):1256-1264. PMID: 28551400.
      View in: PubMed
    23. Sprague BL, Arao RF, Miglioretti DL, Henderson LM, Buist DS, Onega T, Rauscher GH, Lee JM, Tosteson AN, Kerlikowske K, Lehman CD. National Performance Benchmarks for Modern Diagnostic Digital Mammography: Update from the Breast Cancer Surveillance Consortium. Radiology. 2017 Apr; 283(1):59-69. PMID: 28244803.
      View in: PubMed
    24. Engmann NJ, Scott CG, Jensen MR, Ma L, Brandt KR, Mahmoudzadeh AP, Malkov S, Whaley DH, Hruska CB, Wu FF, Winham SJ, Miglioretti DL, Norman AD, Heine JJ, Shepherd J, Pankratz VS, Vachon CM, Kerlikowske K. Longitudinal Changes in Volumetric Breast Density with Tamoxifen and Aromatase Inhibitors. Cancer Epidemiol Biomarkers Prev. 2017 06; 26(6):930-937. PMID: 28148596.
      View in: PubMed
    25. Brandzel S, Rosenberg DE, Johnson D, Bush M, Kerlikowske K, Onega T, Henderson L, Nekhlyudov L, DeMartini W, Wernli KJ. Women's experiences and preferences regarding breast imaging after completing breast cancer treatment. Patient Prefer Adherence. 2017; 11:199-204. PMID: 28203064.
      View in: PubMed
    26. Ziv E, Tice JA, Sprague B, Vachon CM, Cummings SR, Kerlikowske K. Using Breast Cancer Risk Associated Polymorphisms to Identify Women for Breast Cancer Chemoprevention. PLoS One. 2017; 12(1):e0168601. PMID: 28107349.
      View in: PubMed
    27. Ahern TP, Sprague BL, Bissell MCS, Miglioretti DL, Buist DSM, Braithwaite D, Kerlikowske K. Family History of Breast Cancer, Breast Density, and Breast Cancer Risk in a U.S. Breast Cancer Screening Population. Cancer Epidemiol Biomarkers Prev. 2017 06; 26(6):938-944. PMID: 28096200.
      View in: PubMed
    28. Malkov S, Shepherd JA, Scott CG, Tamimi RM, Ma L, Bertrand KA, Couch F, Jensen MR, Mahmoudzadeh AP, Fan B, Norman A, Brandt KR, Pankratz VS, Vachon CM, Kerlikowske K. Erratum to: Mammographic texture and risk of breast cancer by tumor type and estrogen receptor status. Breast Cancer Res. 2017 01 04; 19(1):1. PMID: 28052757.
      View in: PubMed
    29. Menes TS, Kerlikowske K, Lange J, Jaffer S, Rosenberg R, Miglioretti DL. Subsequent Breast Cancer Risk Following Diagnosis of Atypical Ductal Hyperplasia on Needle Biopsy. JAMA Oncol. 2017 Jan 01; 3(1):36-41. PMID: 27607465.
      View in: PubMed
    30. Kerlikowske K, Gard CC, Tice JA, Ziv E, Cummings SR, Miglioretti DL. Risk Factors That Increase Risk of Estrogen Receptor-Positive and -Negative Breast Cancer. J Natl Cancer Inst. 2017 05; 109(5). PMID: 28040694.
      View in: PubMed
    31. Malkov S, Shepherd JA, Scott CG, Tamimi RM, Ma L, Bertrand KA, Couch F, Jensen MR, Mahmoudzadeh AP, Fan B, Norman A, Brandt KR, Pankratz VS, Vachon CM, Kerlikowske K. Mammographic texture and risk of breast cancer by tumor type and estrogen receptor status. Breast Cancer Res. 2016 12 06; 18(1):122. PMID: 27923387.
      View in: PubMed
    32. Lehman CD, Arao RF, Sprague BL, Lee JM, Buist DS, Kerlikowske K, Henderson LM, Onega T, Tosteson AN, Rauscher GH, Miglioretti DL. National Performance Benchmarks for Modern Screening Digital Mammography: Update from the Breast Cancer Surveillance Consortium. Radiology. 2017 Apr; 283(1):49-58. PMID: 27918707.
      View in: PubMed
    33. Onega T, Smith M, Miglioretti DL, Carney PA, Geller BA, Kerlikowske K, Buist DS, Rosenberg RD, Smith RA, Sickles EA, Haneuse S, Anderson ML, Yankaskas B. Radiologist Agreement for Mammographic Recall by Case Difficulty and Finding Type. J Am Coll Radiol. 2016 Nov; 13(11S):e72-e79. PMID: 27814827.
      View in: PubMed
    34. Shieh Y, Hu D, Ma L, Huntsman S, Gard CC, Leung JW, Tice JA, Vachon CM, Cummings SR, Kerlikowske K, Ziv E. Breast cancer risk prediction using a clinical risk model and polygenic risk score. Breast Cancer Res Treat. 2016 Oct; 159(3):513-25. PMID: 27565998; PMCID: PMC5033764 [Available on 10/01/17].
    35. Sherman ME, Ichikawa L, Pfeiffer RM, Miglioretti DL, Kerlikowske K, Tice J, Vacek PM, Gierach GL. Relationship of Predicted Risk of Developing Invasive Breast Cancer, as Assessed with Three Models, and Breast Cancer Mortality among Breast Cancer Patients. PLoS One. 2016; 11(8):e0160966. PMID: 27560501; PMCID: PMC4999085.
    36. Goodrich ME, Weiss J, Onega T, Balch SL, Buist DS, Kerlikowske K, Henderson LM, Hubbard RA. The Role of Preoperative Magnetic Resonance Imaging in the Assessment and Surgical Treatment of Interval and Screen-Detected Breast Cancer in Older Women. Breast J. 2016 Nov; 22(6):616-622. PMID: 27550072.
      View in: PubMed
    37. Trentham-Dietz A, Kerlikowske K, Stout NK, Miglioretti DL, Schechter CB, Ergun MA, van den Broek JJ, Alagoz O, Sprague BL, van Ravesteyn NT, Near AM, Gangnon RE, Hampton JM, Chandler Y, de Koning HJ, Mandelblatt JS, Tosteson AN. Tailoring Breast Cancer Screening Intervals by Breast Density and Risk for Women Aged 50 Years or Older: Collaborative Modeling of Screening Outcomes. Ann Intern Med. 2016 Nov 15; 165(10):700-712. PMID: 27548583.
      View in: PubMed
    38. Onega T, Weiss JE, Buist DS, Tosteson AN, Henderson LM, Kerlikowske K, Goodrich ME, O'Donoghue C, Wernli KJ, DeMartini WB, Virnig BA, Bennette CS, Hubbard RA. Breast MRI in the Diagnostic and Preoperative Workup Among Medicare Beneficiaries With Breast Cancer. Med Care. 2016 07; 54(7):719-24. PMID: 27111752; PMCID: PMC5001851 [Available on 07/01/17].
    39. Ozanne EM, Weiss JE, Onega T, DeMartini W, Kerlikowske K, Buist DS, Henderson L, Hubbard RA, Goodrich M, Tosteson AN, Virnig BA, O'Donoghue C. Locoregional treatment of breast cancer in women with and without preoperative magnetic resonance imaging. Am J Surg. 2017 Jan; 213(1):132-139.e2. PMID: 27421187.
      View in: PubMed
    40. Molinaro AM, Sison JD, Ljung BM, Tlsty TD, Kerlikowske K. Risk prediction for local versus regional/metastatic tumors after initial ductal carcinoma in situ diagnosis treated by lumpectomy. Breast Cancer Res Treat. 2016 06; 157(2):351-361. PMID: 27146587.
      View in: PubMed
    41. Kerlikowske K, Vachon CM. Breast Density: More Than Meets the Eye. J Natl Cancer Inst. 2016 Oct; 108(10). PMID: 27130894.
      View in: PubMed
    42. Kerlikowske K. Progress Toward Consensus on Breast Cancer Screening Guidelines and Reducing Screening Harms--Reply. JAMA Intern Med. 2016 Apr; 176(4):562-3. PMID: 27043108.
      View in: PubMed
    43. Fenton JJ, Onega T, Zhu W, Balch S, Smith-Bindman R, Henderson L, Sprague BL, Kerlikowske K, Hubbard RA. Validation of a Medicare Claims-based Algorithm for Identifying Breast Cancers Detected at Screening Mammography. Med Care. 2016 Mar; 54(3):e15-22. PMID: 23929404; PMCID: PMC3865072 [Available on 03/01/17].
    44. Onega T, Tosteson AN, Weiss J, Alford-Teaster J, Hubbard RA, Henderson LM, Kerlikowske K, Goodrich ME, O'Donoghue C, Wernli KJ, DeMartini WB, Virnig BA. Costs of diagnostic and preoperative workup with and without breast MRI in older women with a breast cancer diagnosis. BMC Health Serv Res. 2016 Feb 27; 16:76. PMID: 26920552; PMCID: PMC4769533.
    45. Braithwaite D, Walter LC, Izano M, Kerlikowske K. Benefits and Harms of Screening Mammography by Comorbidity and Age: A Qualitative Synthesis of Observational Studies and Decision Analyses. J Gen Intern Med. 2016 May; 31(5):561-72. PMID: 26831305; PMCID: PMC4835373 [Available on 05/01/17].
    46. Nelson HD, O'Meara ES, Kerlikowske K, Balch S, Miglioretti D. Factors Associated With Rates of False-Positive and False-Negative Results From Digital Mammography Screening: An Analysis of Registry Data. Ann Intern Med. 2016 Feb 16; 164(4):226-35. PMID: 26756902.
      View in: PubMed
    47. Mandelblatt JS, Stout NK, Schechter CB, van den Broek JJ, Miglioretti DL, Krapcho M, Trentham-Dietz A, Munoz D, Lee SJ, Berry DA, van Ravesteyn NT, Alagoz O, Kerlikowske K, Tosteson AN, Near AM, Hoeffken A, Chang Y, Heijnsdijk EA, Chisholm G, Huang X, Huang H, Ergun MA, Gangnon R, Sprague BL, Plevritis S, Feuer E, de Koning HJ, Cronin KA. Collaborative Modeling of the Benefits and Harms Associated With Different U.S. Breast Cancer Screening Strategies. Ann Intern Med. 2016 Feb 16; 164(4):215-25. PMID: 26756606.
      View in: PubMed
    48. Miglioretti DL, Lange J, van den Broek JJ, Lee CI, van Ravesteyn NT, Ritley D, Kerlikowske K, Fenton JJ, Melnikow J, de Koning HJ, Hubbard RA. Radiation-Induced Breast Cancer Incidence and Mortality From Digital Mammography Screening: A Modeling Study. Ann Intern Med. 2016 Feb 16; 164(4):205-14. PMID: 26756460; PMCID: PMC4878445.
    49. Brandt KR, Scott CG, Ma L, Mahmoudzadeh AP, Jensen MR, Whaley DH, Wu FF, Malkov S, Hruska CB, Norman AD, Heine J, Shepherd J, Pankratz VS, Kerlikowske K, Vachon CM. Comparison of Clinical and Automated Breast Density Measurements: Implications for Risk Prediction and Supplemental Screening. Radiology. 2016 Jun; 279(3):710-9. PMID: 26694052; PMCID: PMC4886704 [Available on 06/01/17].
    50. Kerlikowske K. Progress Toward Consensus on Breast Cancer Screening Guidelines and Reducing Screening Harms. JAMA Intern Med. 2015 Dec; 175(12):1970-1. PMID: 26502319; PMCID: PMC4869718.
    51. Henderson LM, Hubbard RA, Sprague BL, Zhu W, Kerlikowske K. Increased Risk of Developing Breast Cancer after a False-Positive Screening Mammogram. Cancer Epidemiol Biomarkers Prev. 2015 Dec; 24(12):1882-9. PMID: 26631292; PMCID: PMC4670607 [Available on 12/01/16].
    52. Lehman CD, Wellman RD, Buist DS, Kerlikowske K, Tosteson AN, Miglioretti DL. Diagnostic Accuracy of Digital Screening Mammography With and Without Computer-Aided Detection. JAMA Intern Med. 2015 Nov; 175(11):1828-37. PMID: 26414882; PMCID: PMC4836172 [Available on 11/01/16].
    53. Miglioretti DL, Zhu W, Kerlikowske K, Sprague BL, Onega T, Buist DS, Henderson LM, Smith RA. Breast Tumor Prognostic Characteristics and Biennial vs Annual Mammography, Age, and Menopausal Status. JAMA Oncol. 2015 Nov; 1(8):1069-77. PMID: 26501844; PMCID: PMC4644100 [Available on 11/01/16].
    54. Henderson LM, Weiss J, Hubbard RA, O'Donoghue C, DeMartini WB, Buist DS, Kerlikowske K, Goodrich M, Virnig B, Tosteson AN, Lehman CD, Onega T. Factors Associated with Preoperative Magnetic Resonance Imaging Use among Medicare Beneficiaries with Nonmetastatic Breast Cancer. Breast J. 2016 Jan-Feb; 22(1):24-34. PMID: 26511204; PMCID: PMC4718842 [Available on 01/01/17].
    55. Livaudais-Toman J, Karliner LS, Tice JA, Kerlikowske K, Gregorich S, Pérez-Stable EJ, Pasick RJ, Chen A, Quinn J, Kaplan CP. Impact of a primary care based intervention on breast cancer knowledge, risk perception and concern: A randomized, controlled trial. Breast. 2015 Dec; 24(6):758-66. PMID: 26476466.
      View in: PubMed
    56. Henderson LM, Miglioretti DL, Kerlikowske K, Wernli KJ, Sprague BL, Lehman CD. Breast Cancer Characteristics Associated With Digital Versus Film-Screen Mammography for Screen-Detected and Interval Cancers. AJR Am J Roentgenol. 2015 Sep; 205(3):676-84. PMID: 26295657; PMCID: PMC4547477.
    57. Hart V, Reeves KW, Sturgeon SR, Reich NG, Sievert LL, Kerlikowske K, Ma L, Shepherd J, Tice JA, Mahmoudzadeh AP, Malkov S, Sprague BL. The effect of change in body mass index on volumetric measures of mammographic density. Cancer Epidemiol Biomarkers Prev. 2015 Nov; 24(11):1724-30. PMID: 26315554; PMCID: PMC4633314 [Available on 11/01/16].
    58. Tice JA, Miglioretti DL, Li CS, Vachon CM, Gard CC, Kerlikowske K. Breast Density and Benign Breast Disease: Risk Assessment to Identify Women at High Risk of Breast Cancer. J Clin Oncol. 2015 Oct 01; 33(28):3137-43. PMID: 26282663; PMCID: PMC4582144 [Available on 10/01/16].
    59. Jackson SL, Abraham L, Miglioretti DL, Buist DS, Kerlikowske K, Onega T, Carney PA, Sickles EA, Elmore JG. Patient and Radiologist Characteristics Associated With Accuracy of Two Types of Diagnostic Mammograms. AJR Am J Roentgenol. 2015 Aug; 205(2):456-63. PMID: 26204300; PMCID: PMC4809354.
    60. Chien AJ, Duralde E, Hwang R, Tsung K, Kao CN, Rugo HS, Melisko ME, Esserman LJ, Munster PN, Cedars M, Kerlikowske K, McCulloch CE, Rosen MP. Association of tamoxifen use and ovarian function in patients with invasive or pre-invasive breast cancer. Breast Cancer Res Treat. 2015 Aug; 153(1):173-81. PMID: 26208485.
      View in: PubMed
    61. Kemp Jacobsen K, O'Meara ES, Key D, S M Buist D, Kerlikowske K, Vejborg I, Sprague BL, Lynge E, von Euler-Chelpin M. Comparing sensitivity and specificity of screening mammography in the United States and Denmark. Int J Cancer. 2015 Nov 01; 137(9):2198-207. PMID: 25944711; PMCID: PMC4537675 [Available on 11/01/16].
    62. Kemp Jacobsen K, Abraham L, Buist DS, Hubbard RA, O'Meara ES, Sprague BL, Kerlikowske K, Vejborg I, Von Euler-Chelpin M, Njor SH. Comparison of cumulative false-positive risk of screening mammography in the United States and Denmark. Cancer Epidemiol. 2015 Aug; 39(4):656-63. PMID: 26013768; PMCID: PMC4871241.
    63. Kerlikowske K, Zhu W, Tosteson AN, Sprague BL, Tice JA, Lehman CD, Miglioretti DL. Identifying women with dense breasts at high risk for interval cancer: a cohort study. Ann Intern Med. 2015 May 19; 162(10):673-81. PMID: 25984843; PMCID: PMC4443857.
    64. Torres-Mejía G, Smith RA, Carranza-Flores Mde L, Bogart A, Martínez-Matsushita L, Miglioretti DL, Kerlikowske K, Ortega-Olvera C, Montemayor-Varela E, Angeles-Llerenas A, Bautista-Arredondo S, Sánchez-González G, Martínez-Montañez OG, Uscanga-Sánchez SR, Lazcano-Ponce E, Hernández-Ávila M. Radiographers supporting radiologists in the interpretation of screening mammography: a viable strategy to meet the shortage in the number of radiologists. BMC Cancer. 2015 May 16; 15:410. PMID: 25975383; PMCID: PMC4436872.
    65. Sprague BL, Gangnon RE, Hampton JM, Egan KM, Titus LJ, Kerlikowske K, Remington PL, Newcomb PA, Trentham-Dietz A. Variation in Breast Cancer-Risk Factor Associations by Method of Detection: Results From a Series of Case-Control Studies. Am J Epidemiol. 2015 Jun 15; 181(12):956-69. PMID: 25944893; PMCID: PMC4462335.
    66. Kerlikowske K, Gard CC, Sprague BL, Tice JA, Miglioretti DL. One versus Two Breast Density Measures to Predict 5- and 10-Year Breast Cancer Risk. Cancer Epidemiol Biomarkers Prev. 2015 Jun; 24(6):889-97. PMID: 25824444; PMCID: PMC4452451.
    67. Vachon CM, Pankratz VS, Scott CG, Haeberle L, Ziv E, Jensen MR, Brandt KR, Whaley DH, Olson JE, Heusinger K, Hack CC, Jud SM, Beckmann MW, Schulz-Wendtland R, Tice JA, Norman AD, Cunningham JM, Purrington KS, Easton DF, Sellers TA, Kerlikowske K, Fasching PA, Couch FJ. The contributions of breast density and common genetic variation to breast cancer risk. J Natl Cancer Inst. 2015 May; 107(5). PMID: 25745020; PMCID: PMC4598340.
    68. Bertrand KA, Scott CG, Tamimi RM, Jensen MR, Pankratz VS, Norman AD, Visscher DW, Couch FJ, Shepherd J, Chen YY, Fan B, Wu FF, Ma L, Beck AH, Cummings SR, Kerlikowske K, Vachon CM. Dense and nondense mammographic area and risk of breast cancer by age and tumor characteristics. Cancer Epidemiol Biomarkers Prev. 2015 May; 24(5):798-809. PMID: 25716949; PMCID: PMC4417380.
    69. Sprague BL, Stout NK, Schechter C, van Ravesteyn NT, Cevik M, Alagoz O, Lee CI, van den Broek JJ, Miglioretti DL, Mandelblatt JS, de Koning HJ, Kerlikowske K, Lehman CD, Tosteson AN. Benefits, harms, and cost-effectiveness of supplemental ultrasonography screening for women with dense breasts. Ann Intern Med. 2015 Feb 03; 162(3):157-66. PMID: 25486550; PMCID: PMC4314343.
    70. Allison KH, Abraham LA, Weaver DL, Tosteson AN, Nelson HD, Onega T, Geller BM, Kerlikowske K, Carney PA, Ichikawa LE, Buist DS, Elmore JG. Trends in breast biopsy pathology diagnoses among women undergoing mammography in the United States: a report from the Breast Cancer Surveillance Consortium. Cancer. 2015 May 01; 121(9):1369-78. PMID: 25603785; PMCID: PMC4419038.
    71. Lee CI, Cevik M, Alagoz O, Sprague BL, Tosteson AN, Miglioretti DL, Kerlikowske K, Stout NK, Jarvik JG, Ramsey SD, Lehman CD. Comparative effectiveness of combined digital mammography and tomosynthesis screening for women with dense breasts. Radiology. 2015 Mar; 274(3):772-80. PMID: 25350548; PMCID: PMC4455673.
    72. Sprague BL, Gangnon RE, Burt V, Trentham-Dietz A, Hampton JM, Wellman RD, Kerlikowske K, Miglioretti DL. Prevalence of mammographically dense breasts in the United States. J Natl Cancer Inst. 2014 Oct; 106(10). PMID: 25217577; PMCID: PMC4200066.
    73. DeFilippis RA, Fordyce C, Patten K, Chang H, Zhao J, Fontenay GV, Kerlikowske K, Parvin B, Tlsty TD. Stress signaling from human mammary epithelial cells contributes to phenotypes of mammographic density. Cancer Res. 2014 Sep 15; 74(18):5032-5044. PMID: 25172842; PMCID: PMC4335659.
    74. Ponti A, Lynge E, James T, Májek O, von Euler-Chelpin M, Anttila A, Fitzpatrick P, Mano MP, Kawai M, Scharpantgen A, Fracheboud J, Hofvind S, Vidal C, Ascunce N, Salas D, Bulliard JL, Segnan N, Kerlikowske K, Taplin S. International variation in management of screen-detected ductal carcinoma in situ of the breast. Eur J Cancer. 2014 Oct; 50(15):2695-704. PMID: 25149183.
      View in: PubMed
    75. Ayvaci MU, Alagoz O, Chhatwal J, Munoz del Rio A, Sickles EA, Nassif H, Kerlikowske K, Burnside ES. Predicting invasive breast cancer versus DCIS in different age groups. BMC Cancer. 2014 Aug 11; 14:584. PMID: 25112586; PMCID: PMC4138370.
    76. Onega T, Weiss J, Kerlikowske K, Wernli K, Buist DS, Henderson LM, Goodrich M, Alford-Teaster J, Virnig B, Tosteson AN, DeMartini W, Hubbard R. The influence of race/ethnicity and place of service on breast reconstruction for Medicare beneficiaries with mastectomy. Springerplus. 2014; 3:416. PMID: 25140292; PMCID: PMC4137047.
    77. Lee CI, Ichikawa L, Rochelle MC, Kerlikowske K, Miglioretti DL, Sprague BL, DeMartini WB, Wernli KJ, Joe BN, Yankaskas BC, Lehman CD. Breast MRI BI-RADS assessments and abnormal interpretation rates by clinical indication in US community practices. Acad Radiol. 2014 Nov; 21(11):1370-6. PMID: 25126973.
      View in: PubMed
    78. Kerlikowske K, Hubbard R, Tosteson AN. Higher mammography screening costs without appreciable clinical benefit: the case of digital mammography. J Natl Cancer Inst. 2014 Aug; 106(8). PMID: 25031310.
      View in: PubMed
    79. Bolton KC, Mace JL, Vacek PM, Herschorn SD, James TA, Tice JA, Kerlikowske K, Geller BM, Weaver DL, Sprague BL. Changes in breast cancer risk distribution among Vermont women using screening mammography. J Natl Cancer Inst. 2014 Aug; 106(8). PMID: 24957223; PMCID: PMC4375382.
    80. Onega T, Hubbard R, Hill D, Lee CI, Haas JS, Carlos HA, Alford-Teaster J, Bogart A, DeMartini WB, Kerlikowske K, Virnig BA, Buist DS, Henderson L, Tosteson AN. Geographic access to breast imaging for US women. J Am Coll Radiol. 2014 Sep; 11(9):874-82. PMID: 24889479; PMCID: PMC4156905.
    81. Geller BM, Bogart A, Carney PA, Sickles EA, Smith R, Monsees B, Bassett LW, Buist DM, Kerlikowske K, Onega T, Yankaskas BC, Haneuse S, Hill D, Wallis MG, Miglioretti D. Educational interventions to improve screening mammography interpretation: a randomized controlled trial. AJR Am J Roentgenol. 2014 Jun; 202(6):W586-96. PMID: 24848854; PMCID: PMC4276372.
    82. Stout NK, Lee SJ, Schechter CB, Kerlikowske K, Alagoz O, Berry D, Buist DS, Cevik M, Chisholm G, de Koning HJ, Huang H, Hubbard RA, Miglioretti DL, Munsell MF, Trentham-Dietz A, van Ravesteyn NT, Tosteson AN, Mandelblatt JS. Benefits, harms, and costs for breast cancer screening after US implementation of digital mammography. J Natl Cancer Inst. 2014 Jun; 106(6):dju092. PMID: 24872543; PMCID: PMC4067109.
    83. Prebil LA, Ereman RR, Powell MJ, Jamshidian F, Kerlikowske K, Shepherd JA, Hurlbert MS, Benz CC. First pregnancy events and future breast density: modification by age at first pregnancy and specific VEGF and IGF1R gene variants. Cancer Causes Control. 2014 Jul; 25(7):859-68. PMID: 24801045; PMCID: PMC4048469.
    84. Kerlikowske K, O'Kane ME, Esserman LJ. Fifty years of age-based screening: time for a new risk-based screening approach. Evid Based Med. 2014 Oct; 19(5):183. PMID: 24785471.
      View in: PubMed
    85. Kaplan CP, Livaudais-Toman J, Tice JA, Kerlikowske K, Gregorich SE, Pérez-Stable EJ, Pasick RJ, Chen A, Quinn J, Karliner LS. A randomized, controlled trial to increase discussion of breast cancer in primary care. Cancer Epidemiol Biomarkers Prev. 2014 Jul; 23(7):1245-53. PMID: 24762560; PMCID: PMC4167008.
    86. Malkov S, Kerlikowske K, Shepherd J. Automated Volumetric Breast Density derived by Shape and Appearance Modeling. Proc SPIE Int Soc Opt Eng. 2014 Mar 22; 9034:90342T. PMID: 25083119.
      View in: PubMed
    87. Izano M, Satariano WA, Tammemagi MC, Ragland D, Moore DH, Allen E, Naeim A, Sehl ME, Hiatt RA, Kerlikowske K, Sofrygin O, Braithwaite D. Long-term outcomes among African-American and white women with breast cancer: what is the impact of comorbidity? J Geriatr Oncol. 2014 Jul; 5(3):266-75. PMID: 24613574.
      View in: PubMed
    88. Drukker K, Duewer F, Giger ML, Malkov S, Flowers CI, Joe B, Kerlikowske K, Drukteinis JS, Li H, Shepherd JA. Mammographic quantitative image analysis and biologic image composition for breast lesion characterization and classification. Med Phys. 2014 Mar; 41(3):031915. PMID: 24593733; PMCID: PMC3978370.
    89. Wernli KJ, DeMartini WB, Ichikawa L, Lehman CD, Onega T, Kerlikowske K, Henderson LM, Geller BM, Hofmann M, Yankaskas BC. Patterns of breast magnetic resonance imaging use in community practice. JAMA Intern Med. 2014 Jan; 174(1):125-32. PMID: 24247555; PMCID: PMC3905972.
    90. Fehniger J, Livaudais-Toman J, Karliner L, Kerlikowske K, Tice JA, Quinn J, Ozanne E, Kaplan CP. Perceived versus objective breast cancer risk in diverse women. J Womens Health (Larchmt). 2014 May; 23(5):420-7. PMID: 24372085; PMCID: PMC4011422.
    91. Wernli KJ, O'Meara ES, Kerlikowske K, Miglioretti DL, Muller CY, Onega T, Sprague BL, Henderson LM, Buist DS. Investigation of mammographic breast density as a risk factor for ovarian cancer. J Natl Cancer Inst. 2014 Jan; 106(1):djt341. PMID: 24309005; PMCID: PMC3906993.
    92. Wang J, Azziz A, Fan B, Malkov S, Klifa C, Newitt D, Yitta S, Hylton N, Kerlikowske K, Shepherd JA. Agreement of mammographic measures of volumetric breast density to MRI. PLoS One. 2013; 8(12):e81653. PMID: 24324712; PMCID: PMC3852736.
    93. Bertrand KA, Tamimi RM, Scott CG, Jensen MR, Pankratz V, Visscher D, Norman A, Couch F, Shepherd J, Fan B, Chen YY, Ma L, Beck AH, Cummings SR, Kerlikowske K, Vachon CM. Mammographic density and risk of breast cancer by age and tumor characteristics. Breast Cancer Res. 2013 Nov 04; 15(6):R104. PMID: 24188089; PMCID: PMC3978749.
    94. Carney PA, Bogart A, Sickles EA, Smith R, Buist DS, Kerlikowske K, Onega T, Miglioretti DL, Rosenberg R, Yankaskas BC, Geller BM. Feasibility and acceptability of conducting a randomized clinical trial designed to improve interpretation of screening mammography. Acad Radiol. 2013 Nov; 20(11):1389-98. PMID: 24119351.
      View in: PubMed
    95. Menes TS, Rosenberg R, Balch S, Jaffer S, Kerlikowske K, Miglioretti DL. Upgrade of high-risk breast lesions detected on mammography in the Breast Cancer Surveillance Consortium. Am J Surg. 2014 Jan; 207(1):24-31. PMID: 24112677; PMCID: PMC3865063.
    96. Schairer C, Li Y, Frawley P, Graubard BI, Wellman RD, Buist DS, Kerlikowske K, Onega TL, Anderson WF, Miglioretti DL. Risk factors for inflammatory breast cancer and other invasive breast cancers. J Natl Cancer Inst. 2013 Sep 18; 105(18):1373-84. PMID: 24046390; PMCID: PMC3776263.
    97. Lynge E, Ponti A, James T, Májek O, von Euler-Chelpin M, Anttila A, Fitzpatrick P, Frigerio A, Kawai M, Scharpantgen A, Broeders M, Hofvind S, Vidal C, Ederra M, Salas D, Bulliard JL, Tomatis M, Kerlikowske K, Taplin S. Variation in detection of ductal carcinoma in situ during screening mammography: a survey within the International Cancer Screening Network. Eur J Cancer. 2014 Jan; 50(1):185-92. PMID: 24041876.
      View in: PubMed
    98. O'Meara ES, Zhu W, Hubbard RA, Braithwaite D, Kerlikowske K, Dittus KL, Geller B, Wernli KJ, Miglioretti DL. Mammographic screening interval in relation to tumor characteristics and false-positive risk by race/ethnicity and age. Cancer. 2013 Nov 15; 119(22):3959-67. PMID: 24037812; PMCID: PMC3935985.
    99. Dittus K, Geller B, Weaver DL, Kerlikowske K, Zhu W, Hubbard R, Braithwaite D, O'Meara ES, Miglioretti DL. Impact of mammography screening interval on breast cancer diagnosis by menopausal status and BMI. J Gen Intern Med. 2013 Nov; 28(11):1454-62. PMID: 23760741; PMCID: PMC3797353.
    100. Tice JA, O'Meara ES, Weaver DL, Vachon C, Ballard-Barbash R, Kerlikowske K. Benign breast disease, mammographic breast density, and the risk of breast cancer. J Natl Cancer Inst. 2013 Jul 17; 105(14):1043-9. PMID: 23744877; PMCID: PMC3714021.
    101. Braithwaite D, Mandelblatt JS, Kerlikowske K. To screen or not to screen older women for breast cancer: a conundrum. Future Oncol. 2013 Jun; 9(6):763-6. PMID: 23718292; PMCID: PMC3745823.
    102. Onega T, Anderson ML, Miglioretti DL, Buist DS, Geller B, Bogart A, Smith RA, Sickles EA, Monsees B, Bassett L, Carney PA, Kerlikowske K, Yankaskas BC. Establishing a gold standard for test sets: variation in interpretive agreement of expert mammographers. Acad Radiol. 2013 Jun; 20(6):731-9. PMID: 23664400.
      View in: PubMed
    103. Caswell JL, Kerlikowske K, Shepherd JA, Cummings SR, Hu D, Huntsman S, Ziv E. High mammographic density in women of Ashkenazi Jewish descent. Breast Cancer Res. 2013 May 13; 15(3):R40. PMID: 23668689; PMCID: PMC4053164.
    104. Kerlikowske K, Zhu W, Hubbard RA, Geller B, Dittus K, Braithwaite D, Wernli KJ, Miglioretti DL, O'Meara ES. Outcomes of screening mammography by frequency, breast density, and postmenopausal hormone therapy. JAMA Intern Med. 2013 May 13; 173(9):807-16. PMID: 23552817; PMCID: PMC3699693.
    105. Goldman LE, Walker R, Hubbard R, Kerlikowske K. Timeliness of abnormal screening and diagnostic mammography follow-up at facilities serving vulnerable women. Med Care. 2013 Apr; 51(4):307-14. PMID: 23358386; PMCID: PMC3966312.
    106. Houssami N, Abraham LA, Kerlikowske K, Buist DS, Irwig L, Lee J, Miglioretti DL. Risk factors for second screen-detected or interval breast cancers in women with a personal history of breast cancer participating in mammography screening. Cancer Epidemiol Biomarkers Prev. 2013 May; 22(5):946-61. PMID: 23513042; PMCID: PMC3650092.
    107. Braithwaite D, Zhu W, Hubbard RA, O'Meara ES, Miglioretti DL, Geller B, Dittus K, Moore D, Wernli KJ, Mandelblatt J, Kerlikowske K. Screening outcomes in older US women undergoing multiple mammograms in community practice: does interval, age, or comorbidity score affect tumor characteristics or false positive rates? J Natl Cancer Inst. 2013 Mar 06; 105(5):334-41. PMID: 23385442; PMCID: PMC3589257.
    108. Harvey JA, Gard CC, Miglioretti DL, Yankaskas BC, Kerlikowske K, Buist DS, Geller BA, Onega TL. Reported mammographic density: film-screen versus digital acquisition. Radiology. 2013 Mar; 266(3):752-8. PMID: 23249570; PMCID: PMC3579169.
    109. Smith RA, Kerlikowske K, Miglioretti DL, Kalager M. Clinical decisions. Mammography screening for breast cancer. N Engl J Med. 2012 Nov 22; 367(21):e31. PMID: 23171121.
      View in: PubMed
    110. Onega T, Smith M, Miglioretti DL, Carney PA, Geller BA, Kerlikowske K, Buist DS, Rosenberg RD, Smith RA, Sickles EA, Haneuse S, Anderson ML, Yankaskas B. Radiologist agreement for mammographic recall by case difficulty and finding type. J Am Coll Radiol. 2012 Nov; 9(11):788-94. PMID: 23122345.
      View in: PubMed
    111. Braithwaite D, Izano M, Moore DH, Kwan ML, Tammemagi MC, Hiatt RA, Kerlikowske K, Kroenke CH, Sweeney C, Habel L, Castillo A, Weltzien E, Caan B. Smoking and survival after breast cancer diagnosis: a prospective observational study and systematic review. Breast Cancer Res Treat. 2012 Nov; 136(2):521-33. PMID: 23053660; PMCID: PMC3507472.
    112. Gierach GL, Ichikawa L, Kerlikowske K, Brinton LA, Farhat GN, Vacek PM, Weaver DL, Schairer C, Taplin SH, Sherman ME. Relationship between mammographic density and breast cancer death in the Breast Cancer Surveillance Consortium. J Natl Cancer Inst. 2012 Aug 22; 104(16):1218-27. PMID: 22911616; PMCID: PMC3611814.
    113. DeFilippis RA, Chang H, Dumont N, Rabban JT, Chen YY, Fontenay GV, Berman HK, Gauthier ML, Zhao J, Hu D, Marx JJ, Tjoe JA, Ziv E, Febbraio M, Kerlikowske K, Parvin B, Tlsty TD. CD36 repression activates a multicellular stromal program shared by high mammographic density and tumor tissues. Cancer Discov. 2012 Sep; 2(9):826-39. PMID: 22777768; PMCID: PMC3457705.
    114. Yasmeen S, Hubbard RA, Romano PS, Zhu W, Geller BM, Onega T, Yankaskas BC, Miglioretti DL, Kerlikowske K. Risk of advanced-stage breast cancer among older women with comorbidities. Cancer Epidemiol Biomarkers Prev. 2012 Sep; 21(9):1510-9. PMID: 22744339; PMCID: PMC3730817.
    115. van Ravesteyn NT, Miglioretti DL, Stout NK, Lee SJ, Schechter CB, Buist DS, Huang H, Heijnsdijk EA, Trentham-Dietz A, Alagoz O, Near AM, Kerlikowske K, Nelson HD, Mandelblatt JS, de Koning HJ. Tipping the balance of benefits and harms to favor screening mammography starting at age 40 years: a comparative modeling study of risk. Ann Intern Med. 2012 May 01; 156(9):609-17. PMID: 22547470; PMCID: PMC3520058.
    116. Nelson HD, Zakher B, Cantor A, Fu R, Griffin J, O'Meara ES, Buist DS, Kerlikowske K, van Ravesteyn NT, Trentham-Dietz A, Mandelblatt JS, Miglioretti DL. Risk factors for breast cancer for women aged 40 to 49 years: a systematic review and meta-analysis. Ann Intern Med. 2012 May 01; 156(9):635-48. PMID: 22547473; PMCID: PMC3561467.
    117. Carney PA, Bogart TA, Geller BM, Haneuse S, Kerlikowske K, Buist DS, Smith R, Rosenberg R, Yankaskas BC, Onega T, Miglioretti DL. Association between time spent interpreting, level of confidence, and accuracy of screening mammography. AJR Am J Roentgenol. 2012 Apr; 198(4):970-8. PMID: 22451568; PMCID: PMC3654687.
    118. Phipps AI, Buist DS, Malone KE, Barlow WE, Porter PL, Kerlikowske K, O'Meara ES, Li CI. Breast density, body mass index, and risk of tumor marker-defined subtypes of breast cancer. Ann Epidemiol. 2012 May; 22(5):340-8. PMID: 22366170; PMCID: PMC3338877.
    119. Buist DS, Walker R, Bowles EJ, Carney PA, Taplin SH, Onega T, Kerlikowske K, Clinton W, Miglioretti DL. Screening mammography use among current, former, and never hormone therapy users may not explain recent declines in breast cancer incidence. Cancer Epidemiol Biomarkers Prev. 2012 May; 21(5):720-7. PMID: 22301831; PMCID: PMC3348383.
    120. Kerlikowske K. Screening mammography in women less than age 50 years. Curr Opin Obstet Gynecol. 2012 Feb; 24(1):38-43. PMID: 22037165.
      View in: PubMed
    121. Karliner LS, Ma L, Hofmann M, Kerlikowske K. Language barriers, location of care, and delays in follow-up of abnormal mammograms. Med Care. 2012 Feb; 50(2):171-8. PMID: 21993060; PMCID: PMC3918470.
    122. Shepherd JA, Kerlikowske K. Do fatty breasts increase or decrease breast cancer risk? Breast Cancer Res. 2012 Jan 25; 14(1):102. PMID: 22277587; PMCID: PMC3496115.
    123. Lorizio W, Wu AH, Beattie MS, Rugo H, Tchu S, Kerlikowske K, Ziv E. Clinical and biomarker predictors of side effects from tamoxifen. Breast Cancer Res Treat. 2012 Apr; 132(3):1107-18. PMID: 22207277; PMCID: PMC3335925.
    124. Haneuse S, Buist DS, Miglioretti DL, Anderson ML, Carney PA, Onega T, Geller BM, Kerlikowske K, Rosenberg RD, Yankaskas BC, Elmore JG, Taplin SH, Smith RA, Sickles EA. Mammographic interpretive volume and diagnostic mammogram interpretation performance in community practice. Radiology. 2012 Jan; 262(1):69-79. PMID: 22106351; PMCID: PMC3244665.
    125. Hubbard RA, Kerlikowske K, Flowers CI, Yankaskas BC, Zhu W, Miglioretti DL. Cumulative probability of false-positive recall or biopsy recommendation after 10 years of screening mammography: a cohort study. Ann Intern Med. 2011 Oct 18; 155(8):481-92. PMID: 22007042; PMCID: PMC3209800.
    126. Kerlikowske K, Hubbard RA, Miglioretti DL, Geller BM, Yankaskas BC, Lehman CD, Taplin SH, Sickles EA. Comparative effectiveness of digital versus film-screen mammography in community practice in the United States: a cohort study. Ann Intern Med. 2011 Oct 18; 155(8):493-502. PMID: 22007043; PMCID: PMC3726800.
    127. Carney PA, Cook AJ, Miglioretti DL, Feig SA, Bowles EA, Geller BM, Kerlikowske K, Kettler M, Onega T, Elmore JG. Use of clinical history affects accuracy of interpretive performance of screening mammography. J Clin Epidemiol. 2012 Feb; 65(2):219-30. PMID: 22000816; PMCID: PMC3253253.
    128. Hubbard R, Kerlikowske K, Buist D, Yankaskas B. Evaluation of breast cancer screening strategies must be based on comparison of harms and benefits. AJR Am J Roentgenol. 2011 Oct; 197(4):W793; author reply 794. PMID: 21940562.
      View in: PubMed
    129. Kerlikowske K, Phipps AI. Breast density influences tumor subtypes and tumor aggressiveness. J Natl Cancer Inst. 2011 Aug 03; 103(15):1143-5. PMID: 21795663; PMCID: PMC3149045.
    130. Schousboe JT, Kerlikowske K, Loh A, Cummings SR. Personalizing mammography by breast density and other risk factors for breast cancer: analysis of health benefits and cost-effectiveness. Ann Intern Med. 2011 Jul 05; 155(1):10-20. PMID: 21727289; PMCID: PMC3759993.
    131. Shepherd JA, Kerlikowske K, Ma L, Duewer F, Fan B, Wang J, Malkov S, Vittinghoff E, Cummings SR. Volume of mammographic density and risk of breast cancer. Cancer Epidemiol Biomarkers Prev. 2011 Jul; 20(7):1473-82. PMID: 21610220; PMCID: PMC3132306.
    132. Houssami N, Abraham LA, Miglioretti DL, Sickles EA, Kerlikowske K, Buist DS, Geller BM, Muss HB, Irwig L. Accuracy and outcomes of screening mammography in women with a personal history of early-stage breast cancer. JAMA. 2011 Feb 23; 305(8):790-9. PMID: 21343578; PMCID: PMC3799940.
    133. Buist DS, Anderson ML, Haneuse SJ, Sickles EA, Smith RA, Carney PA, Taplin SH, Rosenberg RD, Geller BM, Onega TL, Monsees BS, Bassett LW, Yankaskas BC, Elmore JG, Kerlikowske K, Miglioretti DL. Influence of annual interpretive volume on screening mammography performance in the United States. Radiology. 2011 Apr; 259(1):72-84. PMID: 21343539; PMCID: PMC3064821.
    134. Goldman LE, Walker R, Miglioretti DL, Smith-Bindman R, Kerlikowske K. Accuracy of diagnostic mammography at facilities serving vulnerable women. Med Care. 2011 Jan; 49(1):67-75. PMID: 20966780; PMCID: PMC3689881.
    135. Phipps AI, Buist DS, Malone KE, Barlow WE, Porter PL, Kerlikowske K, Li CI. Reproductive history and risk of three breast cancer subtypes defined by three biomarkers. Cancer Causes Control. 2011 Mar; 22(3):399-405. PMID: 21184265; PMCID: PMC3042513.
    136. Farhat GN, Walker R, Buist DS, Onega T, Kerlikowske K. Changes in invasive breast cancer and ductal carcinoma in situ rates in relation to the decline in hormone therapy use. J Clin Oncol. 2010 Dec 10; 28(35):5140-6. PMID: 21060026; PMCID: PMC3020688.
    137. DeMartini WB, Ichikawa L, Yankaskas BC, Buist D, Kerlikowske K, Geller B, Onega T, Rosenberg RD, Lehman CD. Breast MRI in community practice: equipment and imaging techniques at facilities in the Breast Cancer Surveillance Consortium. J Am Coll Radiol. 2010 Nov; 7(11):878-84. PMID: 21040870; PMCID: PMC2994070.
    138. Onega T, Aiello Bowles EJ, Miglioretti DL, Carney PA, Geller BM, Yankaskas BC, Kerlikowske K, Sickles EA, Elmore JG. Radiologists' perceptions of computer aided detection versus double reading for mammography interpretation. Acad Radiol. 2010 Oct; 17(10):1217-26. PMID: 20832024; PMCID: PMC3149895.
    139. Braithwaite D, Satariano WA, Sternfeld B, Hiatt RA, Ganz PA, Kerlikowske K, Moore DH, Slattery ML, Tammemagi M, Castillo A, Melisko M, Esserman L, Weltzien EK, Caan BJ. Long-term prognostic role of functional limitations among women with breast cancer. J Natl Cancer Inst. 2010 Oct 06; 102(19):1468-77. PMID: 20861456; PMCID: PMC2950169.
    140. Phipps AI, Buist DS, Malone KE, Barlow WE, Porter PL, Kerlikowske K, Li CI. Family history of breast cancer in first-degree relatives and triple-negative breast cancer risk. Breast Cancer Res Treat. 2011 Apr; 126(3):671-8. PMID: 20814817; PMCID: PMC3059326.
    141. Buist DS, Abraham LA, Barlow WE, Krishnaraj A, Holdridge RC, Sickles EA, Carney PA, Kerlikowske K, Geller BM. Diagnosis of second breast cancer events after initial diagnosis of early stage breast cancer. Breast Cancer Res Treat. 2010 Dec; 124(3):863-73. PMID: 20700648; PMCID: PMC2976764.
    142. Kerlikowske K, Cook AJ, Buist DS, Cummings SR, Vachon C, Vacek P, Miglioretti DL. Breast cancer risk by breast density, menopause, and postmenopausal hormone therapy use. J Clin Oncol. 2010 Aug 20; 28(24):3830-7. PMID: 20644098; PMCID: PMC2940400.
    143. Kerlikowske K. A call for evidence of benefits outweighing harms before implementing new technologies: comment on "Diffusion of computer-aided mammography after mandated Medicare coverage". Arch Intern Med. 2010 Jun 14; 170(11):990-1. PMID: 20548014.
      View in: PubMed
    144. Elmore JG, Aiello Bowles EJ, Geller B, Oster NV, Carney PA, Miglioretti DL, Buist DS, Kerlikowske K, Sickles EA, Onega T, Rosenberg RD, Yankaskas BC. Radiologists' attitudes and use of mammography audit reports. Acad Radiol. 2010 Jun; 17(6):752-60. PMID: 20457418; PMCID: PMC2894027.
    145. Phipps AI, Li CI, Kerlikowske K, Barlow WE, Buist DS. Risk factors for ductal, lobular, and mixed ductal-lobular breast cancer in a screening population. Cancer Epidemiol Biomarkers Prev. 2010 Jun; 19(6):1643-54. PMID: 20501751; PMCID: PMC2882996.
    146. Phipps AI, Ichikawa L, Bowles EJ, Carney PA, Kerlikowske K, Miglioretti DL, Buist DS. Defining menopausal status in epidemiologic studies: A comparison of multiple approaches and their effects on breast cancer rates. Maturitas. 2010 Sep; 67(1):60-6. PMID: 20494530; PMCID: PMC2922404.
    147. Yankaskas BC, Haneuse S, Kapp JM, Kerlikowske K, Geller B, Buist DS. Performance of first mammography examination in women younger than 40 years. J Natl Cancer Inst. 2010 May 19; 102(10):692-701. PMID: 20439838; PMCID: PMC2902813.
    148. Kerlikowske K, Molinaro AM, Gauthier ML, Berman HK, Waldman F, Bennington J, Sanchez H, Jimenez C, Stewart K, Chew K, Ljung BM, Tlsty TD. Biomarker expression and risk of subsequent tumors after initial ductal carcinoma in situ diagnosis. J Natl Cancer Inst. 2010 May 05; 102(9):627-37. PMID: 20427430; PMCID: PMC2864293.
    149. Laidevant AD, Malkov S, Flowers CI, Kerlikowske K, Shepherd JA. Compositional breast imaging using a dual-energy mammography protocol. Med Phys. 2010 Jan; 37(1):164-74. PMID: 20175478; PMCID: PMC2801735.
    150. Kerlikowske K. Epidemiology of ductal carcinoma in situ. J Natl Cancer Inst Monogr. 2010; 2010(41):139-41. PMID: 20956818.
      View in: PubMed
    151. Malkov S, Wang J, Kerlikowske K, Cummings SR, Shepherd JA. Single x-ray absorptiometry method for the quantitative mammographic measure of fibroglandular tissue volume. Med Phys. 2009 Dec; 36(12):5525-36. PMID: 20095265; PMCID: PMC2789112.
    152. Kerlikowske K. Evidence-based breast cancer prevention: the importance of individual risk. Ann Intern Med. 2009 Nov 17; 151(10):750-2. PMID: 19920276.
      View in: PubMed
    153. Menes TS, Kerlikowske K, Jaffer S, Seger D, Miglioretti DL. Rates of atypical ductal hyperplasia have declined with less use of postmenopausal hormone treatment: findings from the Breast Cancer Surveillance Consortium. Cancer Epidemiol Biomarkers Prev. 2009 Nov; 18(11):2822-8. PMID: 19900937; PMCID: PMC2920735.
    154. Elmore JG, Jackson SL, Abraham L, Miglioretti DL, Carney PA, Geller BM, Yankaskas BC, Kerlikowske K, Onega T, Rosenberg RD, Sickles EA, Buist DS. Variability in interpretive performance at screening mammography and radiologists' characteristics associated with accuracy. Radiology. 2009 Dec; 253(3):641-51. PMID: 19864507; PMCID: PMC2786197.
    155. Miglioretti DL, Gard CC, Carney PA, Onega TL, Buist DS, Sickles EA, Kerlikowske K, Rosenberg RD, Yankaskas BC, Geller BM, Elmore JG. When radiologists perform best: the learning curve in screening mammogram interpretation. Radiology. 2009 Dec; 253(3):632-40. PMID: 19789234; PMCID: PMC2786195.
    156. Tice JA, Kerlikowske K. Screening and prevention of breast cancer in primary care. Prim Care. 2009 Sep; 36(3):533-58. PMID: 19616154.
      View in: PubMed
    157. Gallagher TH, Cook AJ, Brenner RJ, Carney PA, Miglioretti DL, Geller BM, Kerlikowske K, Onega TL, Rosenberg RD, Yankaskas BC, Lehman CD, Elmore JG. Disclosing harmful mammography errors to patients. Radiology. 2009 Nov; 253(2):443-52. PMID: 19710002; PMCID: PMC2770115.
    158. Cummings SR, Tice JA, Bauer S, Browner WS, Cuzick J, Ziv E, Vogel V, Shepherd J, Vachon C, Smith-Bindman R, Kerlikowske K. Prevention of breast cancer in postmenopausal women: approaches to estimating and reducing risk. J Natl Cancer Inst. 2009 Mar 18; 101(6):384-98. PMID: 19276457; PMCID: PMC2720698.
    159. Venkatesan A, Chu P, Kerlikowske K, Sickles EA, Smith-Bindman R. Positive predictive value of specific mammographic findings according to reader and patient variables. Radiology. 2009 Mar; 250(3):648-57. PMID: 19164116; PMCID: PMC2680167.
    160. Kerlikowske K, Walker R, Miglioretti DL, Desai A, Ballard-Barbash R, Buist DS. Obesity, mammography use and accuracy, and advanced breast cancer risk. J Natl Cancer Inst. 2008 Dec 03; 100(23):1724-33. PMID: 19033562; PMCID: PMC2734114.
    161. Park CC, Rembert J, Chew K, Moore D, Kerlikowske K. High mammographic breast density is independent predictor of local but not distant recurrence after lumpectomy and radiotherapy for invasive breast cancer. Int J Radiat Oncol Biol Phys. 2009 Jan 01; 73(1):75-9. PMID: 18692323.
      View in: PubMed
    162. Goldman LE, Haneuse SJ, Miglioretti DL, Kerlikowske K, Buist DS, Yankaskas B, Smith-Bindman R. An assessment of the quality of mammography care at facilities treating medically vulnerable populations. Med Care. 2008 Jul; 46(7):701-8. PMID: 18580389; PMCID: PMC2674332.
    163. Tice JA, Cummings SR, Smith-Bindman R, Ichikawa L, Barlow WE, Kerlikowske K. Using clinical factors and mammographic breast density to estimate breast cancer risk: development and validation of a new predictive model. Ann Intern Med. 2008 Mar 04; 148(5):337-47. PMID: 18316752; PMCID: PMC2674327.
    164. Smith-Bindman R, Miglioretti DL, Rosenberg R, Reid RJ, Taplin SH, Geller BM, Kerlikowske K. Physician workload in mammography. AJR Am J Roentgenol. 2008 Feb; 190(2):526-32. PMID: 18212242.
      View in: PubMed
    165. Hwang ES, Miglioretti DL, Ballard-Barbash R, Weaver DL, Kerlikowske K. Association between breast density and subsequent breast cancer following treatment for ductal carcinoma in situ. Cancer Epidemiol Biomarkers Prev. 2007 Dec; 16(12):2587-93. PMID: 18086762.
      View in: PubMed
    166. Karliner LS, Kerlikowske K. Ethnic disparities in breast cancer. Womens Health (Lond). 2007 Nov; 3(6):679-88. PMID: 19803977.
      View in: PubMed
    167. Gauthier ML, Berman HK, Miller C, Kozakeiwicz K, Chew K, Moore D, Rabban J, Chen YY, Kerlikowske K, Tlsty TD. Abrogated response to cellular stress identifies DCIS associated with subsequent tumor events and defines basal-like breast tumors. Cancer Cell. 2007 Nov; 12(5):479-91. PMID: 17996651; PMCID: PMC3605202.
    168. Kerlikowske K, Miglioretti DL, Buist DS, Walker R, Carney PA. Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population. J Natl Cancer Inst. 2007 Sep 05; 99(17):1335-9. PMID: 17698950.
      View in: PubMed
    169. Kerlikowske K, Ichikawa L, Miglioretti DL, Buist DS, Vacek PM, Smith-Bindman R, Yankaskas B, Carney PA, Ballard-Barbash R. Longitudinal measurement of clinical mammographic breast density to improve estimation of breast cancer risk. J Natl Cancer Inst. 2007 Mar 07; 99(5):386-95. PMID: 17341730.
      View in: PubMed
    170. Karliner LS, Napoles-Springer A, Kerlikowske K, Haas JS, Gregorich SE, Kaplan CP. Missed opportunities: family history and behavioral risk factors in breast cancer risk assessment among a multiethnic group of women. J Gen Intern Med. 2007 Mar; 22(3):308-14. PMID: 17356960; PMCID: PMC1824768.
    171. Phillips KA, Liang SY, Ladabaum U, Haas J, Kerlikowske K, Lieberman D, Hiatt R, Nagamine M, Van Bebber SL. Trends in colonoscopy for colorectal cancer screening. Med Care. 2007 Feb; 45(2):160-7. PMID: 17224779.
      View in: PubMed
    172. Carney PA, Abraham LA, Miglioretti DL, Yabroff KR, Sickles EA, Buist DS, Kasales CJ, Geller BM, Rosenberg RD, Dignan MB, Weaver DL, Kerlikowske K. Factors associated with imaging and procedural events used to detect breast cancer after screening mammography. AJR Am J Roentgenol. 2007 Feb; 188(2):385-92. PMID: 17242246.
      View in: PubMed
    173. Kerlikowske K. The mammogram that cried Wolfe. N Engl J Med. 2007 Jan 18; 356(3):297-300. PMID: 17229958.
      View in: PubMed
    174. Haas JS, Miglioretti DL, Geller B, Buist DS, Nelson DE, Kerlikowske K, Carney PA, Dash S, Breslau ES, Ballard-Barbash R. Average household exposure to newspaper coverage about the harmful effects of hormone therapy and population-based declines in hormone therapy use. J Gen Intern Med. 2007 Jan; 22(1):68-73. PMID: 17351842; PMCID: PMC1824785.
    175. Geller BM, Ichikawa LE, Buist DS, Sickles EA, Carney PA, Yankaskas BC, Dignan M, Kerlikowske K, Yabroff KR, Barlow W, Rosenberg RD. Improving the concordance of mammography assessment and management recommendations. Radiology. 2006 Oct; 241(1):67-75. PMID: 16990672.
      View in: PubMed
    176. Rosenberg RD, Yankaskas BC, Abraham LA, Sickles EA, Lehman CD, Geller BM, Carney PA, Kerlikowske K, Buist DS, Weaver DL, Barlow WE, Ballard-Barbash R. Performance benchmarks for screening mammography. Radiology. 2006 Oct; 241(1):55-66. PMID: 16990671.
      View in: PubMed
    177. Barlow WE, White E, Ballard-Barbash R, Vacek PM, Titus-Ernstoff L, Carney PA, Tice JA, Buist DS, Geller BM, Rosenberg R, Yankaskas BC, Kerlikowske K. Prospective breast cancer risk prediction model for women undergoing screening mammography. J Natl Cancer Inst. 2006 Sep 06; 98(17):1204-14. PMID: 16954473.
      View in: PubMed
    178. Shepherd JA, Herve L, Landau J, Fan B, Kerlikowske K, Cummings SR. Clinical comparison of a novel breast DXA technique to mammographic density. Med Phys. 2006 May; 33(5):1490-8. PMID: 16752583.
      View in: PubMed
    179. Smith-Bindman R, Quale C, Chu PW, Rosenberg R, Kerlikowske K. Can Medicare billing claims data be used to assess mammography utilization among women ages 65 and older? Med Care. 2006 May; 44(5):463-70. PMID: 16641665.
      View in: PubMed
    180. Smith-Bindman R, Miglioretti DL, Lurie N, Abraham L, Barbash RB, Strzelczyk J, Dignan M, Barlow WE, Beasley CM, Kerlikowske K. Does utilization of screening mammography explain racial and ethnic differences in breast cancer? Ann Intern Med. 2006 Apr 18; 144(8):541-53. PMID: 16618951.
      View in: PubMed
    181. Haas JS, Geller B, Miglioretti DL, Buist DS, Nelson DE, Kerlikowske K, Carney PA, Breslau ES, Dash S, Canales MK, Ballard-Barbash R. Changes in newspaper coverage about hormone therapy with the release of new medical evidence. J Gen Intern Med. 2006 Apr; 21(4):304-9. PMID: 16499542; PMCID: PMC1484740.
    182. Weaver DL, Rosenberg RD, Barlow WE, Ichikawa L, Carney PA, Kerlikowske K, Buist DS, Geller BM, Key CR, Maygarden SJ, Ballard-Barbash R. Pathologic findings from the Breast Cancer Surveillance Consortium: population-based outcomes in women undergoing biopsy after screening mammography. Cancer. 2006 Feb 15; 106(4):732-42. PMID: 16411214.
      View in: PubMed
    183. Kulasingam SL, Myers ER, Lawson HW, McConnell KJ, Kerlikowske K, Melnikow J, Washington AE, Sawaya GF. Cost-effectiveness of extending cervical cancer screening intervals among women with prior normal pap tests. Obstet Gynecol. 2006 Feb; 107(2 Pt 1):321-8. PMID: 16449119.
      View in: PubMed
    184. Kaplan CP, Haas JS, Pérez-Stable EJ, Gregorich SE, Somkin C, Des Jarlais G, Kerlikowske K. Breast cancer risk reduction options: awareness, discussion, and use among women from four ethnic groups. Cancer Epidemiol Biomarkers Prev. 2006 Jan; 15(1):162-6. PMID: 16434605.
      View in: PubMed
    185. Haas JS, Kaplan CP, Des Jarlais G, Gildengoin V, Pérez-Stable EJ, Kerlikowske K. Perceived risk of breast cancer among women at average and increased risk. J Womens Health (Larchmt). 2005 Nov; 14(9):845-51. PMID: 16313212.
      View in: PubMed
    186. Tice JA, Cummings SR, Ziv E, Kerlikowske K. Mammographic breast density and the Gail model for breast cancer risk prediction in a screening population. Breast Cancer Res Treat. 2005 Nov; 94(2):115-22. PMID: 16261410.
      View in: PubMed
    187. Kerlikowske K, Creasman J, Leung JW, Smith-Bindman R, Ernster VL. Differences in screening mammography outcomes among White, Chinese, and Filipino women. Arch Intern Med. 2005 Sep 12; 165(16):1862-8. PMID: 16157830.
      View in: PubMed
    188. Haas JS, Kaplan CP, Brawarsky P, Kerlikowske K. Evaluation and outcomes of women with a breast lump and a normal mammogram result. J Gen Intern Med. 2005 Aug; 20(8):692-6. PMID: 16050876; PMCID: PMC1490178.
    189. Des Jarlais G, Kaplan CP, Haas JS, Gregorich SE, Pérez-Stable EJ, Kerlikowske K. Factors affecting participation in a breast cancer risk reduction telephone survey among women from four racial/ethnic groups. Prev Med. 2005 Sep-Oct; 41(3-4):720-7. PMID: 15936066.
      View in: PubMed
    190. Shepherd JA, Herve L, Landau J, Fan B, Kerlikowske K, Cummings SR. Novel use of single X-ray absorptiometry for measuring breast density. Technol Cancer Res Treat. 2005 Apr; 4(2):173-82. PMID: 15773786.
      View in: PubMed
    191. Kerlikowske K, Shepherd J, Creasman J, Tice JA, Ziv E, Cummings SR. Are breast density and bone mineral density independent risk factors for breast cancer? J Natl Cancer Inst. 2005 Mar 02; 97(5):368-74. PMID: 15741573.
      View in: PubMed
    192. Smith-Bindman R, Chu P, Miglioretti DL, Quale C, Rosenberg RD, Cutter G, Geller B, Bacchetti P, Sickles EA, Kerlikowske K. Physician predictors of mammographic accuracy. J Natl Cancer Inst. 2005 Mar 02; 97(5):358-67. PMID: 15741572.
      View in: PubMed
    193. Kerlikowske K, Smith-Bindman R, Abraham LA, Lehman CD, Yankaskas BC, Ballard-Barbash R, Barlow WE, Voeks JH, Geller BM, Carney PA, Sickles EA. Breast cancer yield for screening mammographic examinations with recommendation for short-interval follow-up. Radiology. 2005 Mar; 234(3):684-92. PMID: 15734926.
      View in: PubMed
    194. Yankaskas BC, Taplin SH, Ichikawa L, Geller BM, Rosenberg RD, Carney PA, Kerlikowske K, Ballard-Barbash R, Cutter GR, Barlow WE. Association between mammography timing and measures of screening performance in the United States. Radiology. 2005 Feb; 234(2):363-73. PMID: 15670994.
      View in: PubMed
    195. Smith-Bindman R, Ballard-Barbash R, Miglioretti DL, Patnick J, Kerlikowske K. Comparing the performance of mammography screening in the USA and the UK. J Med Screen. 2005; 12(1):50-4. PMID: 15814020.
      View in: PubMed
    196. Kerlikowske K. How do personal characteristics affect sensitivity and specificity of mammography? Nat Clin Pract Oncol. 2005 Jan; 2(1):16-7. PMID: 16264848.
      View in: PubMed
    197. White E, Miglioretti DL, Yankaskas BC, Geller BM, Rosenberg RD, Kerlikowske K, Saba L, Vacek PM, Carney PA, Buist DS, Oestreicher N, Barlow W, Ballard-Barbash R, Taplin SH. Biennial versus annual mammography and the risk of late-stage breast cancer. J Natl Cancer Inst. 2004 Dec 15; 96(24):1832-9. PMID: 15601639.
      View in: PubMed
    198. Ziv E, Tice J, Smith-Bindman R, Shepherd J, Cummings S, Kerlikowske K. Mammographic density and estrogen receptor status of breast cancer. Cancer Epidemiol Biomarkers Prev. 2004 Dec; 13(12):2090-5. PMID: 15598766.
      View in: PubMed
    199. Haggstrom DA, Phillips KA, Liang SY, Haas JS, Tye S, Kerlikowske K. Variation in screening mammography and Papanicolaou smear by primary care physician specialty and gatekeeper plan (United States). Cancer Causes Control. 2004 Nov; 15(9):883-92. PMID: 15577290.
      View in: PubMed
    200. Kerlikowske K, Miglioretti DL. Effects of estrogen-only treatment in postmenopausal women. JAMA. 2004 Aug 11; 292(6):684-5; author reply 685-6. PMID: 15304459.
      View in: PubMed
    201. Hwang ES, DeVries S, Chew KL, Moore DH, Kerlikowske K, Thor A, Ljung BM, Waldman FM. Patterns of chromosomal alterations in breast ductal carcinoma in situ. Clin Cancer Res. 2004 Aug 01; 10(15):5160-7. PMID: 15297420.
      View in: PubMed
    202. Haas JS, Kaplan CP, Gerstenberger EP, Kerlikowske K. Changes in the use of postmenopausal hormone therapy after the publication of clinical trial results. Ann Intern Med. 2004 Feb 03; 140(3):184-8. PMID: 14757616.
      View in: PubMed
    203. Phillips KA, Haas JS, Liang SY, Baker LC, Tye S, Kerlikowske K, Sakowski J, Spetz J. Are gatekeeper requirements associated with cancer screening utilization? Health Serv Res. 2004 Feb; 39(1):153-78. PMID: 14965082; PMCID: PMC1360999.
    204. Miglioretti DL, Rutter CM, Geller BM, Cutter G, Barlow WE, Rosenberg R, Weaver DL, Taplin SH, Ballard-Barbash R, Carney PA, Yankaskas BC, Kerlikowske K. Effect of breast augmentation on the accuracy of mammography and cancer characteristics. JAMA. 2004 Jan 28; 291(4):442-50. PMID: 14747501.
      View in: PubMed
    205. Kerlikowske K, Miglioretti DL, Ballard-Barbash R, Weaver DL, Buist DS, Barlow WE, Cutter G, Geller BM, Yankaskas B, Taplin SH, Carney PA. Prognostic characteristics of breast cancer among postmenopausal hormone users in a screened population. J Clin Oncol. 2003 Dec 01; 21(23):4314-21. PMID: 14645420.
      View in: PubMed
    206. Kerlikowske K, Molinaro A, Cha I, Ljung BM, Ernster VL, Stewart K, Chew K, Moore DH, Waldman F. Characteristics associated with recurrence among women with ductal carcinoma in situ treated by lumpectomy. J Natl Cancer Inst. 2003 Nov 19; 95(22):1692-702. PMID: 14625260.
      View in: PubMed
    207. Smith-Bindman R, Chu PW, Miglioretti DL, Sickles EA, Blanks R, Ballard-Barbash R, Bobo JK, Lee NC, Wallis MG, Patnick J, Kerlikowske K. Comparison of screening mammography in the United States and the United kingdom. JAMA. 2003 Oct 22; 290(16):2129-37. PMID: 14570948.
      View in: PubMed
    208. Sawaya GF, McConnell KJ, Kulasingam SL, Lawson HW, Kerlikowske K, Melnikow J, Lee NC, Gildengorin G, Myers ER, Washington AE. Risk of cervical cancer associated with extending the interval between cervical-cancer screenings. N Engl J Med. 2003 Oct 16; 349(16):1501-9. PMID: 14561792.
      View in: PubMed
    209. Geller BM, Kerlikowske K, Carney PA, Abraham LA, Yankaskas BC, Taplin SH, Ballard-Barbash R, Dignan MB, Rosenberg R, Urban N, Barlow WE. Mammography surveillance following breast cancer. Breast Cancer Res Treat. 2003 Sep; 81(2):107-15. PMID: 14572153.
      View in: PubMed
    210. Kerlikowske K, Smith-Bindman R, Ljung BM, Grady D. Evaluation of abnormal mammography results and palpable breast abnormalities. Ann Intern Med. 2003 Aug 19; 139(4):274-84. PMID: 12965983.
      View in: PubMed
    211. Ziv E, Shepherd J, Smith-Bindman R, Kerlikowske K. Mammographic breast density and family history of breast cancer. J Natl Cancer Inst. 2003 Apr 02; 95(7):556-8. PMID: 12671024.
      View in: PubMed
    212. Kerlikowske K, Smith-Bindman R, Sickles EA. Short-interval follow-up mammography: are we doing the right thing? J Natl Cancer Inst. 2003 Mar 19; 95(6):418-9. PMID: 12644528.
      View in: PubMed
    213. Carney PA, Miglioretti DL, Yankaskas BC, Kerlikowske K, Rosenberg R, Rutter CM, Geller BM, Abraham LA, Taplin SH, Dignan M, Cutter G, Ballard-Barbash R. Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography. Ann Intern Med. 2003 Feb 04; 138(3):168-75. PMID: 12558355.
      View in: PubMed
    214. Corley DA, Kerlikowske K, Verma R, Buffler P. Protective association of aspirin/NSAIDs and esophageal cancer: a systematic review and meta-analysis. Gastroenterology. 2003 Jan; 124(1):47-56. PMID: 12512029.
      View in: PubMed
    215. Prevrhal S, Shepherd JA, Smith-Bindman R, Cummings SR, Kerlikowske K. Accuracy of mammographic breast density analysis: results of formal operator training. Cancer Epidemiol Biomarkers Prev. 2002 Nov; 11(11):1389-93. PMID: 12433716.
      View in: PubMed
    216. Ernster VL, Ballard-Barbash R, Barlow WE, Zheng Y, Weaver DL, Cutter G, Yankaskas BC, Rosenberg R, Carney PA, Kerlikowske K, Taplin SH, Urban N, Geller BM. Detection of ductal carcinoma in situ in women undergoing screening mammography. J Natl Cancer Inst. 2002 Oct 16; 94(20):1546-54. PMID: 12381707.
      View in: PubMed
    217. Barlow WE, Lehman CD, Zheng Y, Ballard-Barbash R, Yankaskas BC, Cutter GR, Carney PA, Geller BM, Rosenberg R, Kerlikowske K, Weaver DL, Taplin SH. Performance of diagnostic mammography for women with signs or symptoms of breast cancer. J Natl Cancer Inst. 2002 Aug 07; 94(15):1151-9. PMID: 12165640.
      View in: PubMed
    218. Shepherd JA, Kerlikowske KM, Smith-Bindman R, Genant HK, Cummings SR. Measurement of breast density with dual X-ray absorptiometry: feasibility. Radiology. 2002 May; 223(2):554-7. PMID: 11997567.
      View in: PubMed
    219. Taplin SH, Ichikawa LE, Kerlikowske K, Ernster VL, Rosenberg RD, Yankaskas BC, Carney PA, Geller BM, Urban N, Dignan MB, Barlow WE, Ballard-Barbash R, Sickles EA. Concordance of breast imaging reporting and data system assessments and management recommendations in screening mammography. Radiology. 2002 Feb; 222(2):529-35. PMID: 11818624.
      View in: PubMed